F. D. Piano

Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial†

G. MacGrogan, F. Bidard, O. Trédan, 2016 .

Cancer-associated thrombosis in patients with implanted ports: a prospective multicenter French cohort study (ONCOCIP).

S. Laporte, L. Bertoletti, F. Chauvin, 2018, Blood.

CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial

I. Ray-Coquard, A. Leary, P. Follana, 2020, Clinical Cancer Research.

Efficacy of everolimus in patients with HR+/HER2- high risk early stage breast cancer

J. Lemonnier, M. Campone, D. Cameron, 2021 .

A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1).

J. Grenier, G. MacGrogan, G. MacGrogan, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.